What Does a BioTech Professional Actually Do? A Day in the Life
What does your typical day look like in biotech and pharma? It depends on your role. Here are three professionals in India sharing their daily routines.
Profile 1: Vedavati — Research Scientist, Bangalore (Biocon)
Experience: 6 years | Salary: ₹16L/year ($96K) | Background: MSc Biotechnology
Vedavati works in the biosimilars division at Biocon — India's largest biotech company. She designs experiments to ensure biosimilars (drugs that closely mimic original biologics like insulin) are as effective as the originals.
Vedavati's Day: Tuesday, January 23
8:00 AM - Arrive at Lab Vedavati reaches Biocon's sprawling Bangalore campus. She checks her emails: two from her project manager, one from the analytics team flagging a data inconsistency. She grabs coffee and reviews her experiment plan for the day.
8:30 AM - Lab Safety Brief Daily 15-minute team huddle in the biosafety cabinet area. Her manager reviews the week's experiments: cell culture work, protein expression testing, and analytical studies for an ongoing biosimilar project. Vedavati raises a concern about equipment maintenance — the HPLC (High-Performance Liquid Chromatography, a machine that separates and analyzes drug components) showed drift yesterday. Flagged for technician check.
9:00 AM - Cell Culture Maintenance Vedavati heads to the biosafety cabinets. She checks her mammalian cell cultures growing in bioreactors (large sterile tanks where cells produce proteins). She adjusts pH, nutrient levels, and oxygen. Collects samples for downstream analysis. This is meticulous work — contamination ruins weeks of progress.
10:30 AM - Analytical Testing Samples go to the analytical bench. She runs HPLC and mass spectrometry (a technique identifying molecular weight and structure of drug compounds) to assess protein purity and identity. While waiting for results, she updates her lab notebook (mandatory record-keeping) and reviews the data inconsistency flagged earlier.
12:00 PM - Team Meeting Sits with her team of 5 researchers and 2 technicians. Today's focus: progress on the biosimilar project. Vedavati presents her preliminary results — protein yield is 92%, slightly below target. Discussion: Is it a process issue or analytical variance? Team decides on additional troubleshooting.
1:00 PM - Lunch Cafeteria with colleagues. Discusses weekend plans and a potential conference presentation.
2:00 PM - Data Analysis & Documentation Back at her desk, Vedavati compiles HPLC and mass spectrometry results into her project file using LIMS (Laboratory Information Management System, software that tracks all experiments and results). She flags unexpected findings and calculates yield percentages. This documentation is critical for regulatory submission later.
3:30 PM - Troubleshooting Session The analytical drift from this morning: she reviews calibration logs and confers with the analytics lead. Conclusion: equipment recalibration needed tomorrow. She documents the deviation and corrective action in the system.
4:30 PM - Research Planning With her manager, she discusses next steps for the project. This biosimilar is moving toward clinical trials in 3-4 months. They review the project timeline and identify key bottlenecks: protein expression yield and stability testing.
5:30 PM - Wrap-up Updates her lab notebook, secures samples, ensures equipment is shut down. Sends a summary email to her team about tomorrow's priorities.
6:00 PM - Leave
Profile 2: Chetan — Clinical Research Associate, Mumbai (Parexel CRO)
Experience: 3 years | Salary: ₹6.5L/year ($52K) | Background: B.Pharm
Chetan works for Parexel, a Contract Research Organization (CRO) that manages clinical trials on behalf of pharmaceutical companies. His role: ensure trials run smoothly and data is accurate and compliant.
Chetan's Day: Wednesday, January 24
7:30 AM - Office Commute Mumbai traffic is intense. Chetan listens to a podcast about FDA (US Food and Drug Administration, the regulatory body that approves drugs) compliance updates. His company conducts trials for both Indian and multinational pharma companies.
9:00 AM - Arrive & Daily Standup His team of 8 clinical coordinators gathers. Today's priorities: visit three trial sites to monitor active studies, follow up with a patient enrollment issue, and review adverse event reports. Adverse events (unexpected side effects) must be reported to regulators within 15 days.
9:30 AM - Adverse Event Review Chetan reviews overnight reports from trial sites. One trial participant reported mild nausea after receiving the experimental drug. He assesses severity (mild = not serious), documents it, and determines if it's related to the drug. Not serious enough for immediate escalation, but he flags it for the safety committee's weekly review.
10:00 AM - Site Visit #1 Chetan travels to a trial site (a hospital in Navi Mumbai running Phase II trials — testing drug effectiveness and side effects in larger groups). He meets with the site coordinator:
- Checks enrollment: 40 of 60 patients enrolled. On track.
- Reviews informed consent forms (documents confirming participants agree to the trial).
- Audits 5 patient files randomly: Are all data points recorded? Signatures present? Lab results attached?
- Finds one missing vital sign record. Flags for immediate correction.
12:00 PM - Site Visit #2 Another hospital, another trial. Different protocol (drug being tested), same procedures. This trial is behind on enrollment (28 of 80 patients). He discusses with the site investigator: Are there barriers? Recruitment strategy working? They agree on a revised outreach plan.
2:00 PM - Lunch Quick meal at the hospital cafeteria while reviewing electronic data capture (EDC) — a digital system where all trial data is entered.
2:30 PM - Return to Office Updates his database with site visit findings. Enters discrepancies and corrective action requests. Creates a summary for his team and the sponsors (the pharma companies funding the trial).
3:30 PM - Protocol Compliance Check Reviews the trial protocol (the official study plan) against what sites are actually doing. Found: One site is using a slightly different patient screening criterion than approved. This is a protocol deviation. He creates an incident report and notifies the sponsor.
4:30 PM - Data Quality Audit Chetan pulls data from the EDC system. Spot-checks for errors: missing values, inconsistent dates, out-of-range lab values. Identifies 3 queries to send back to sites for clarification. These must be resolved before final database lock (when trial data becomes read-only and ready for analysis).
5:30 PM - Weekly Safety Report Compiles all adverse events from the week across his trials. Prepares a summary for the Data Safety Monitoring Board (independent experts who ensure trial safety). This report will determine if any trial needs safety adjustments.
6:00 PM - Team Debrief Chetan shares site visit insights with his coordinator. Discusses patient enrollment challenges and strategy adjustments.
6:30 PM - Leave
Profile 3: Shreyas — Quality Assurance Manager, Hyderabad (Serum Institute)
Experience: 8 years | Salary: ₹15L/year ($90K) | Background: B.Pharm + Six Sigma Green Belt
Shreyas oversees quality systems at Serum Institute's vaccine manufacturing facility in Hyderabad. He ensures every batch meets global safety and potency standards.
Shreyas's Day: Thursday, January 25
6:30 AM - Early Start Serum Institute operates 24/7. Shreyas starts before the main shift to review overnight QC (Quality Control) results. Manufacturing doesn't stop. Three vaccine batches are in final testing.
7:00 AM - QC Results Review Batch #2847 (polio vaccine): sterility test passed. Batch #2848 (pneumococcal): potency results pending. Batch #2849 (COVID-19 vaccine): all tests passed; ready for release. Shreyas documents release approvals in LIMS. One batch approved = ready to distribute globally.
8:00 AM - Leadership Meeting Shreyas joins the Quality team (20 QA/QC staff). Discussion: A vendor supplied raw materials with slightly higher water content than specified. This impacts stability. Shreyas leads the investigation: Was it this batch only, or is the vendor process drifting? Decision: quarantine the affected material and audit the supplier next week.
9:00 AM - Process Validation Kick-off Serum is scaling up production of a new vaccine formulation. Shreyas leads validation — proving the manufacturing process consistently produces safe, potent vaccines. He reviews the protocol with his team:
- Three consecutive batches will be extensively tested.
- 150+ data points per batch (sterility, potency, moisture, microbial limits, etc.).
- Must hit all specifications to proceed.
10:00 AM - Lab Tour & Training Shreyas observes two junior QC analysts conducting microbial testing. The stakes are high: a contaminated batch reaching patients could be catastrophic. He watches, verifies technique, and documents competency assessments (mandatory training validation).
11:30 AM - Regulatory Documentation Shreyas works with the Regulatory Affairs team. A batch is being exported to 15 countries. Each requires slightly different documentation. He compiles:
- Certificate of Analysis (test results)
- Stability data
- Manufacturing process records
- Quality agreements
This file goes to regulators in each country.
1:00 PM - Lunch
2:00 PM - Deviation Investigation Earlier, Batch #2848 potency came back slightly lower than usual (though still within acceptable range). Shreyas investigates: Was it an assay (test) variability issue or a process deviation? He pulls manufacturing records: fermentation temperature, pH, nutrient additions. Everything within specification. Conclusion: likely analytical variation. But he documents the investigation thoroughly — regulators audit these files annually.
3:30 PM - Six Sigma Project Shreyas leads a continuous improvement project. They've noticed rejection rates in the microbial testing step are 3% — slightly high. His team is using Six Sigma methods (data-driven process improvement) to identify root causes. Today, they analyze the data: Findings point to environmental control issues in the testing room. Proposed fix: upgraded HVAC (heating/cooling) system. Cost-benefit analysis shows payback in 8 months.
4:30 PM - Compliance Audit Preparation Next month, European regulators will audit Serum's facility. Shreyas prepares documentation:
- Training records for all QA staff.
- Equipment maintenance logs.
- Deviation reports and corrective actions from the past year.
- Standard operating procedures (SOPs).
This is exhaustive work — thousands of documents.
5:30 PM - Strategic Planning With the Quality Director, Shreyas discusses hiring needs. Vaccine demand is rising (India's pharma market growing 10%+ annually). They need 5 additional QA specialists. Shreyas outlines a recruitment plan.
6:30 PM - Leave
Common Threads Across All Three
1. High Accountability Vedavati's contamination mistake could waste months of work. Chetan's data errors could invalidate trial results. Shreyas's oversight could let unsafe vaccines reach patients. All three carry significant responsibility.
2. Regulatory Mindset Documentation, compliance, and traceability aren't bureaucracy — they're essential. FDA and CDSCO reviews these records. One missing signature could delay drug approval by months.
3. Collaboration None work in isolation. Vedavati coordinates with analytics and bioprocess teams. Chetan works with sites, sponsors, and safety committees. Shreyas manages QC analysts and regulators. Teamwork drives success.
4. Balance of Lab & Desk Work Lab work (Vedavati) is hands-on but also involves data analysis. Clinical work (Chetan) is field-based but also very documentation-heavy. Quality (Shreyas) is systematic, analytical, and leadership-focused.
5. Continuous Learning Regulatory changes, new technologies, and scientific advancements mean these professionals constantly upskill. Certifications and conferences aren't optional — they're career essentials.
The Verdict: Is This Career for You?
Choose biotech/pharma if you:
- Love science and want tangible impact.
- Thrive in regulated, high-stakes environments.
- Enjoy problem-solving and data-driven decisions.
- Are detail-oriented and organized.
- Want job security and stable growth.
Reconsider if you:
- Dislike documentation and compliance.
- Prefer fast-paced, unstructured work.
- Are uncomfortable with regulatory timelines.
- Don't enjoy repetitive, meticulous work.
For Vedavati, Chetan, and Shreyas, despite the demands, their work directly improves global health. That's why they stay.